{{Rsnum
|rsid=623011
|Chromosome=17
|position=70263305
|Orientation=plus
|GMAF=0.3398
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.6 | 45.0 | 50.5
| HCB | 16.8 | 54.7 | 28.5
| JPT | 28.3 | 44.2 | 27.4
| YRI | 8.9 | 44.5 | 46.6
| ASW | 3.5 | 35.1 | 61.4
| CHB | 16.8 | 54.7 | 28.5
| CHD | 20.6 | 49.5 | 29.9
| GIH | 1.0 | 29.7 | 69.3
| LWK | 10.0 | 40.0 | 50.0
| MEX | 15.5 | 50.0 | 34.5
| MKK | 5.1 | 39.1 | 55.8
| TSI | 8.8 | 47.1 | 44.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22399142
|Trait=None
|Title=A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis.
|RiskAllele=A
|Pval=4E-12
|OR=5.4700
|ORtxt=None
}}

{{PMID Auto
|PMID=22910584
|Title=Genetic variant rs623011 (17q24.3) associates with non-familial thyrotoxic and sporadic hypokalemic paralysis.
}}

{{on chip | Illumina Human 1M}}